Equity Profile

CRON

Cronos Group Inc.

Health CarePharmaceuticals$1.1B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Cronos Group Inc. is a healthcare company focused on the pharmaceutical industry, particularly in the cannabis sector....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth is crucial for understanding the company's market demand and overall business health.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CRON Q2-2026 Earnings Preview

Context

Company Snapshot

Cronos Group Inc. is a healthcare company focused on the pharmaceutical industry, particularly in the cannabis sector. With a market cap of $1 billion, it plays a significant role in the evolving landscape of medical and recreational cannabis products.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+173.81%

Avg Stock Reaction

+7.89%

Last Quarter Recap

In Q1-2026, Cronos reported an EPS of $0.04, significantly beating expectations of $0.01, resulting in an 8.27% stock increase the following day. However, revenue figures were not disclosed.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, especially after the strong Q1 results. However, the lack of revenue guidance raises concerns about future performance.

Bull Case

If Cronos continues to beat EPS expectations and shows strong revenue growth, it could signal a robust recovery and increased market confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant sell-off, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the strong EPS surprise in the last quarter, investors will be keen to see if this trend continues, which could impact stock sentiment.

Will there be any guidance on revenue growth?

Without revenue guidance, investors may struggle to gauge the company's growth trajectory, making this a critical point of focus.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Cronos to exceed EPS expectations again, given its recent performance.

Supporting Evidence

Cronos has beaten EPS estimates in 60% of the last eight quarters, indicating a trend of positive surprises.

The options market is pricing in a significant move, suggesting that investors expect volatility that could favor a positive outcome.

Key Risk

If EPS comes in below $0.01, it could undermine the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Cronos can maintain its recent performance or if it will revert to previous struggles.

Bull Confirmed If

An EPS of $0.05 or higher would confirm the bullish sentiment and indicate strong operational performance.

Bear Confirmed If

An EPS below $0.01 would confirm bearish concerns and suggest potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±33.86%

Historical Avg

±7.9%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect considerable volatility around the earnings announcement.

Options are pricing ±33.9% while CRON has averaged ±7.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

43.7%

Calls (101K)P/C Ratio: 0.08Puts (8K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cronos beats expectations, history suggests a potential stock increase of around 10.37%, confirming a positive outlook.

In-Line / Cautious

If results are in line but lack strong guidance, the stock may see muted movement as investors reassess their expectations.

Miss

A miss could lead to a decline, with historical data suggesting an average drop of around 7.48% following disappointing results.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth projections for the upcoming quarters.
2Details on cost management strategies that could impact profitability.
3Insights into market demand for Cronos' products in the current economic environment.
4Any commentary on regulatory changes affecting the cannabis industry.
5Management's outlook on competitive positioning within the pharmaceutical sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Cronos Group Inc. is a healthcare company focused on the pharmaceutical industry, particularly in the cannabis sector....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth is crucial for understanding the company's market demand and overall business health.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CRON Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+173.81%

Avg Stock Reaction

+7.89%

Last Quarter Recap

In Q1-2026, Cronos reported an EPS of $0.04, significantly beating expectations of $0.01, resulting in an 8.27% stock increase the following day. However, revenue figures were not disclosed.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, especially after the strong Q1 results. However, the lack of revenue guidance raises concerns about future performance.

Bull Case

If Cronos continues to beat EPS expectations and shows strong revenue growth, it could signal a robust recovery and increased market confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant sell-off, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the strong EPS surprise in the last quarter, investors will be keen to see if this trend continues, which could impact stock sentiment.

Will there be any guidance on revenue growth?

Without revenue guidance, investors may struggle to gauge the company's growth trajectory, making this a critical point of focus.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Cronos to exceed EPS expectations again, given its recent performance.

Supporting Evidence

Cronos has beaten EPS estimates in 60% of the last eight quarters, indicating a trend of positive surprises.

The options market is pricing in a significant move, suggesting that investors expect volatility that could favor a positive outcome.

Key Risk

If EPS comes in below $0.01, it could undermine the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Cronos can maintain its recent performance or if it will revert to previous struggles.

Bull Confirmed If

An EPS of $0.05 or higher would confirm the bullish sentiment and indicate strong operational performance.

Bear Confirmed If

An EPS below $0.01 would confirm bearish concerns and suggest potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±33.86%

Historical Avg

±7.9%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect considerable volatility around the earnings announcement.

Options are pricing ±33.9% while CRON has averaged ±7.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

43.7%

Calls (101K)P/C Ratio: 0.08Puts (8K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cronos beats expectations, history suggests a potential stock increase of around 10.37%, confirming a positive outlook.

In-Line / Cautious

If results are in line but lack strong guidance, the stock may see muted movement as investors reassess their expectations.

Miss

A miss could lead to a decline, with historical data suggesting an average drop of around 7.48% following disappointing results.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth projections for the upcoming quarters.
2Details on cost management strategies that could impact profitability.
3Insights into market demand for Cronos' products in the current economic environment.
4Any commentary on regulatory changes affecting the cannabis industry.
5Management's outlook on competitive positioning within the pharmaceutical sector.